Xenon Pharmaceuticals Announces Proposed Public Offering of Common Shares
BURNABY, British Columbia, March 09, 2021 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical stage biopharmaceutical company, today announced...
News
Lumos Pharma Reports Full Year 2020 Financial Results and Provides Update on OraGrowtH Trials in PGHD
Data published in the Journal of Endocrine Society and accepted for presentation at ENDO 2021 demonstrate distinct mechanism of action...
Soleno to Participate in the 31st Annual Oppenheimer Healthcare Conference
REDWOOD CITY, Calif., March 09, 2021 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing...
Brickell Biotech Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update
Initiated U.S. pivotal Phase 3 clinical program (Cardigan I and II studies) evaluating sofpironium bromide gel, 15% for the treatment...
Gracell Biotechnologies Reports Fourth Quarter and Fiscal Year 2020 Unaudited Financial Results and Provides Corporate Update
Reported interim readouts for lead CAR-T product candidates: FasTCAR-enabled dual-targeting BCMA/CD19 autologous CAR-T product candidate GC012F for the treatment of...
Inari Medical Reports Fourth Quarter and Full Year 2020 Financial Results
IRVINE, Calif., March 09, 2021 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a commercial-stage medical device company focused...
Nurix Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
SAN FRANCISCO, March 09, 2021 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a biopharmaceutical company developing targeted protein modulation...
Jounce Therapeutics Announces Proposed Offering of Common Stock
CAMBRIDGE, Mass., March 09, 2021 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (Nasdaq: JNCE), a clinical-stage company focused on the discovery...
MediciNova Announces Partnership with BARDA to Develop MN-166 (ibudilast) as a Medical Countermeasure Against Chlorine Gas-induced Lung Injury
LA JOLLA, Calif., March 09, 2021 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market...
FDA Warns That Thermal Imaging Systems Pose a Potential Danger to Public Health
Non-Contact Thermometers Have Been Proven to Miss 9 out of 10 Fevers The FDA announced that improper use of thermal...
America Development & Investments, LLC Announces Plans for Reunion Rehabilitation Hospital Plano
The new Reunion Rehabilitation Hospital will provide the Plano community with access to state-of-the-art inpatient rehabilitationPLANO, Texas, March 09, 2021...
PSI Awarded $8.8 Million U.S. Army Europe’s Installation Access Control Support Services Contract
ARLINGTON, Va., March 09, 2021 (GLOBE NEWSWIRE) -- Planned Systems International, Inc. (PSI)—a leading provider of enterprise information technology (IT)...
NABP’s Drug Distributor Accreditation Reaches Milestone of 700 Actively Accredited Facilities
MOUNT PROSPECT, IL, March 09, 2021 (GLOBE NEWSWIRE) -- The National Association of Boards of Pharmacy® (NABP®) is pleased to...
Celularity to Present at H.C. Wainwright Global Life Sciences Conference
Celularity to also participate in a fireside chat and panel discussion with Dr. Scott GottliebFLORHAM PARK, N.J., March 09, 2021...
Bavarian Nordic A/S Seeks to Strengthen its Capital Base and Commits to Ambitious Strategy on Promising COVID-19 Vaccine Candidate
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO THE UNITED STATES, CANADA, JAPAN, SOUTH...
Tauriga Sciences Inc. Completes Payment for the Entirety of its Recently Announced – Largest Tauri-Gum Production Run in Company History
03_09_2021 PR Image All 8 Versions of Tauri-Gum™ Product Line This Production Run Incorporates the Increased CBD & CBG Infusion...
WATS3D Receives Medically Necessary Designation from Blue Cross Blue Shield of Kansas City
Kansas City joins Hawaii Medical Services Association, BCBS South Carolina, and Avalon in considering WATS3D a covered benefitSUFFERN, N.Y., March 09,...
Bavarian Nordic Reports 2021 Financial Guidance
Due to the uncertainty created by COVID-19 the outlook for 2021 will be less specific than usual until there is...
Tecan schedules conference call on March 16 to discuss Full-Year 2020 Financial Results
Männedorf, Switzerland, March 9, 2021 – The Tecan Group (SIX Swiss Exchange: TECN) will hold an Analyst and Media conference...
General Dentist, Gail A Iebba DMD, joins Reading Dental Associates
Gail Iebba DMD, Reading Dentist, specializes in general, cosmetic and emergency dentistry Dr. Gail Iebba DMD Dentist Dr. Gail Iebba...